Accéder au contenu
Merck

Scalable production of transplantable dopaminergic neurons from hESCs and iPSCs in xeno-free defined conditions.

Current protocols in stem cell biology (2012-08-09)
Andrzej Swistowski, Xianmin Zeng
RÉSUMÉ

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are potentially an unlimited cell source for cell replacement therapy and personalized medicine. Before hESC- and iPSC-based therapy can be moved from bench to bedside, however, it is essential to establish protocols for generating therapeutically relevant cells, like dopaminergic neurons in defined conditions that are suitable for scalable good manufacturing practice (GMP)-compliant protocols. Here, the derivation and differentiation of functional dopaminergic neurons from hESCs and iPSCs under xeno-free defined conditions are described. These protocols have been validated in multiple hESC and iPSC lines.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Monoclonal Anti-β-Tubulin III antibody produced in mouse, clone SDL.3D10, ascites fluid
Sigma-Aldrich
Anticorps anti-galactocérébroside, clone mGalC, clone mGalC, Chemicon®, from mouse
Sigma-Aldrich
Anti-Potassium Channel GIRK2 Antibody, Chemicon®, from rabbit